New estimates of drug development costs

[1] *CMR, 2002, P CMR INT 2002 LOND

[2] DiMasi J. A., 2003, J HLTH EC

[3] COST OF INNOVATION IN THE PHARMACEUTICAL-INDUSTRY [J]. JOURNAL OF HEALTH ECONOMICS, 1991, 10 (02) : 107 - 142

[4] *FDA CDER, 2001, REP NAT IMPR HLTH HU

[5] GLUCK M, 2002, FEDERAL POLICY AFFEC

[6] GRESS OTA, 1993, PHARM R D COSTS RISK

[7] *PHRMA, 2001, PHARM IND PROF

[8] PINDYCK RS, 1991, J ECON LIT, V29, P1110

[9] WALKER S, 2002, P DRKW HLTH CAR IND

[10] PRODUCT QUALITY REGULATION AND NEW DRUG INTRODUCTIONS - SOME NEW EVIDENCE FROM THE 1970S [J]. REVIEW OF ECONOMICS AND STATISTICS, 1981, 63 (04) : 615 - 619

[1] *CMR, 2002, P CMR INT 2002 LOND

[2] DiMasi J. A., 2003, J HLTH EC

[3] COST OF INNOVATION IN THE PHARMACEUTICAL-INDUSTRY [J]. JOURNAL OF HEALTH ECONOMICS, 1991, 10 (02) : 107 - 142

[4] *FDA CDER, 2001, REP NAT IMPR HLTH HU

[5] GLUCK M, 2002, FEDERAL POLICY AFFEC

[6] GRESS OTA, 1993, PHARM R D COSTS RISK

[7] *PHRMA, 2001, PHARM IND PROF

[8] PINDYCK RS, 1991, J ECON LIT, V29, P1110

[9] WALKER S, 2002, P DRKW HLTH CAR IND

[10] PRODUCT QUALITY REGULATION AND NEW DRUG INTRODUCTIONS - SOME NEW EVIDENCE FROM THE 1970S [J]. REVIEW OF ECONOMICS AND STATISTICS, 1981, 63 (04) : 615 - 619